257 related articles for article (PubMed ID: 23973342)
21. Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models.
Chiarot E; Spagnuolo A; Maccari S; Naimo E; Acquaviva A; Cecchi R; Galletti B; Fabbrini M; Mori E; Ruggiero P; Grandi G; Fontana MR; Bensi G; Margarit I
Sci Rep; 2018 Feb; 8(1):2593. PubMed ID: 29416049
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.
Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL
J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388
[TBL] [Abstract][Full Text] [Related]
23. Glycoconjugate vaccines to prevent group B streptococcal infections.
Paoletti LC; Kasper DL
Expert Opin Biol Ther; 2003 Sep; 3(6):975-84. PubMed ID: 12943456
[TBL] [Abstract][Full Text] [Related]
24. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
25. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.
Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Carey VJ; Hickman ME; Kasper DL
J Infect Dis; 2000 Oct; 182(4):1129-38. PubMed ID: 10979909
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
[TBL] [Abstract][Full Text] [Related]
27. Neonatal group B streptococcus disease in developing countries: are we ready to deploy a vaccine?
Iroh Tam PY; Delair SF; Obaro SK
Expert Rev Vaccines; 2015; 14(11):1401-3. PubMed ID: 26289974
[TBL] [Abstract][Full Text] [Related]
28. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines.
Edwards MS; Lane HJ; Hillier SL; Rench MA; Baker CJ
Vaccine; 2012 Jun; 30(28):4123-6. PubMed ID: 22537994
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
[TBL] [Abstract][Full Text] [Related]
30. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.
Baker CJ; Rench MA; Fernandez M; Paoletti LC; Kasper DL; Edwards MS
J Infect Dis; 2003 Jul; 188(1):66-73. PubMed ID: 12825173
[TBL] [Abstract][Full Text] [Related]
31. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
[TBL] [Abstract][Full Text] [Related]
33. Structure-based glycoconjugate vaccine design: The example of Group B Streptococcus type III capsular polysaccharide.
Carboni F; Adamo R
Drug Discov Today Technol; 2020 Dec; 35-36():23-33. PubMed ID: 33388125
[TBL] [Abstract][Full Text] [Related]
34. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
35. Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case-control study.
Saukkoriipi A; Silmon de Monerri NC; Toropainen M; Lindholm L; Veijola R; Toppari J; Knip M; Radley D; Gomme E; Jongihlati B; Anderson AS; Palmu AA; Simon R
Lancet Microbe; 2024 Jul; 5(7):689-696. PubMed ID: 38679040
[TBL] [Abstract][Full Text] [Related]
36. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Wessels MR; Paoletti LC; Pinel J; Kasper DL
J Infect Dis; 1995 Apr; 171(4):879-84. PubMed ID: 7706814
[TBL] [Abstract][Full Text] [Related]
38. Group B Streptococcus: Trials and Tribulations.
Davies HG; Carreras-Abad C; Le Doare K; Heath PT
Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S72-S76. PubMed ID: 31205250
[TBL] [Abstract][Full Text] [Related]
39. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
[TBL] [Abstract][Full Text] [Related]
40. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
